1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > North American Radiotherapy Market Outlook - Forecast (2014-2020)

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

This report analyzes the markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities.

This report provides:
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Market share assessments of the top players along with strategic recommendations for the new entrants

Table Of Contents

North American Radiotherapy Market Outlook - Forecast (2014-2020)
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.3.1 Strong Network of the major players
3.3.2 Wide range of product offerings
3.3.3 Increasing usage of Chocolate as a Functional Food
3.4 Market Constraints
3.4.1 Supply Dependency On West African Countries For Cocoa
3.4.2 Sluggish growth in Developed regions
3.4.3 Rapidly changing end user preferences

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Radiotherapy Market by Product Type
5.1 Non-Ionizing Radiation
5.2 Ionizing Radiation
5.3 Particle Radiation
5.4 Electron Beams
5.5 Proton Beams
5.6 Neutron Beams
5.7 Carbon Ions
5.8 Alpha and Beta Particles
5.9 Photon Radiations
5.10 Gamma Rays
5.11 X-rays

6 Radiotherapy Market by Technology
6.1 Intensity Modulated Radiation Therapy (IMRT)
6.2 3-D Conformal Radiotherapy (3D CRT)
6.3 Proton Beam Therapy
6.4 Stereotactic Technology
6.5 Tomotherapy
6.6 Adaptive Radiation Therapy
6.7 Systemic Radiation Therapy

7 Radiotherapy Market by Application
7.1 Lung Cancer
7.2 Colorectal Cancer
7.3 Prostate Cancer
7.4 Breast Cancer
7.5 Head and Neck Cancer
7.6 Brain Cancer
7.7 Spine Cancer
7.8 Cervical Cancer

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Varian Medical Systems
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Siemens Healthcare
10.3 Nordion, Inc
10.4 IBA Group
10.5 GE Healthcare
10.6 Covidien, Plc
10.7 Cardinal Health, Inc.
10.8 Accuray, Inc.
10.9 ANSTO
10.10 C. R. Bard, Inc.
11 Appendix
12 Disclaimer

List of Exhibits
Table 1 North America Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 2 North America Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 3 North America Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 4 North America Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 5 North America Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 6 North America Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 7 North America Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 8 North America Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 9 North America Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 10 North America Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 11 North America Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 12 North America Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 13 North America Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 14 North America Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 15 North America Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 16 North America Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 17 North America Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 18 North America Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 19 North America Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 20 North America Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 21 North America Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 22 North America Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 23 North America Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 24 North America Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 25 North America Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 26 North America Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 27 North America Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 28 North America Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 29 North America Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 30 North America Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 31 US Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 32 US Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 33 US Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 34 US Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 35 US Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 36 US Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 37 US Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 38 US Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 39 US Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 40 US Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 41 US Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 42 US Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 43 US Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 44 US Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 45 US Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 46 US Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 47 US Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 48 US Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 49 US Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 50 US Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 51 US Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 52 US Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 53 US Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 54 US Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 55 US Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 56 US Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 57 US Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 58 US Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 59 US Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 60 US Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 61 Canada Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 62 Canada Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 63 Canada Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 64 Canada Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 65 Canada Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 66 Canada Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 67 Canada Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 68 Canada Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 69 Canada Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 70 Canada Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 71 Canada Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 72 Canada Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 73 Canada Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 74 Canada Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 75 Canada Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 76 Canada Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 77 Canada Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 78 Canada Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 79 Canada Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 80 Canada Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 81 Canada Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 82 Canada Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 83 Canada Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 84 Canada Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 85 Canada Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 86 Canada Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 87 Canada Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 88 Canada Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 89 Canada Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 90 Canada Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.